NewslettersImmune Regulation NewsNewly Issued European Patent Broadens IN8bio’s Drug Resistant Immunotherapy (DRI) PlatformBy lbeveridge - July 21, 20220175IN8bio, Inc. announced the issuance of an additional European patent covering the composition of matter for IN8bio’s Drug Resistant Immunotherapy platform.[IN8bio, Inc.]Press Release